Media

In the media:

EFCCA Magazine: Changing the treatment paradigm for patients with Crohn’s Disease (October 2022)

CarboHyde News: CarboHyde participates in innovative EU-funded research project to change the treatment paradigm for CD patients with new RNA-based therapy (October 2022)

Uppsala University News: New consortium to develop RNA-based treatment for Crohn’s disease (September 2022)

Echo Live (Ireland): UCC project hoping to revolutionise Crohn’s disease treatment awarded €5.4m in funding (July 2022)

Sic Noticias (Portugal): Doença de Crohn: portugueses integram projeto europeu para criar primeira terapia oral (July 2022)

Expresso Portugal: Projeto de €5,4 milhões visa criar terapia oral para a Doença de Crohn (July 2022)

UCC News and Views: UCC awarded €5.4 million funding for next generation treatment for Crohn’s Disease (July 2022)

Capture-echo

Capture-sic

Capture-1

Previous image

Next image

Press Release

Download the first official GENEGUT press release here.

#WhatsOnWednesdays

The monthly social media format covering all things GENEGUT. Follow @GENEGUT_EU to stay up to date!

GENEGUT_WoW (800 × 418 px) (1)

GENEGUT_WoW (2)

Previous image

Next image

Funded by the European Union (GA 101057491) and supported the Swiss State Secretariat for Education, Research and Innovation (SERI) under contract number 22.00119. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them.

UK participants in Horizon Europe Project GENEGUT are supported by UKRI grant number 10042451 (Bangor University).

© 2022 accelopment Schweiz AG · [email protected] · ISO 9001 certified · Read our Privacy Policy and Cookie Policy · Contact GENEGUT